BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 12601173)

  • 1. Immunomic analysis of human sarcoma.
    Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
    Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
    Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
    Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.
    Scanlan MJ; Gout I; Gordon CM; Williamson B; Stockert E; Gure AO; Jäger D; Chen YT; Mackay A; O'Hare MJ; Old LJ
    Cancer Immun; 2001 Mar; 1():4. PubMed ID: 12747765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
    Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
    Jäger D; Stockert E; Güre AO; Scanlan MJ; Karbach J; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 2001 Mar; 61(5):2055-61. PubMed ID: 11280766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).
    Cho HJ; Caballero OL; Gnjatic S; Andrade VC; Colleoni GW; Vettore AL; Outtz HH; Fortunato S; Altorki N; Ferrera CA; Chua R; Jungbluth AA; Chen YT; Old LJ; Simpson AJ
    Cancer Immun; 2006 Dec; 6():12. PubMed ID: 17137291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NY-ESO-1 may be a potential target for lung cancer immunotherapy.
    Lee L; Wang RF; Wang X; Mixon A; Johnson BE; Rosenberg SA; Schrump DS
    Cancer J Sci Am; 1999; 5(1):20-5. PubMed ID: 10188057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].
    Wang Y; Liang Z; Yuan YH; Han Y; Liu YX; Liu N; Chen YT; Ritter G; Old LJ; Zhang LJ
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):464-8. PubMed ID: 15061963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
    Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
    Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer.
    Gure AO; Chua R; Williamson B; Gonen M; Ferrera CA; Gnjatic S; Ritter G; Simpson AJ; Chen YT; Old LJ; Altorki NK
    Clin Cancer Res; 2005 Nov; 11(22):8055-62. PubMed ID: 16299236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer/testis (CT) antigens: potential targets for immunotherapy.
    Caballero OL; Chen YT
    Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
    Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
    Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NY-ESO-1 expression and immunogenicity in esophageal cancer.
    Fujita S; Wada H; Jungbluth AA; Sato S; Nakata T; Noguchi Y; Doki Y; Yasui M; Sugita Y; Yasuda T; Yano M; Ono T; Chen YT; Higashiyama M; Gnjatic S; Old LJ; Nakayama E; Monden M
    Clin Cancer Res; 2004 Oct; 10(19):6551-8. PubMed ID: 15475443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
    Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
    Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.